Accurexa, DelMar Pharma deal

DelMar and Accurexa partnered to develop Accurexa’s ACX-31 implantable polymer wafer to locally deliver DelMar’s VAL-083 in combination with temozolomide and/or carmustine to treat brain cancer and ot...